Cargando…
Gene expression-based biological test for major depressive disorder: an advanced study
PURPOSE: Recently, we could distinguished patients with major depressive disorder (MDD) from nonpsychiatric controls with high accuracy using a panel of five gene expression markers (ARHGAP24, HDAC5, PDGFC, PRNP, and SLC6A4) in leukocyte. In the present study, we examined whether this biological tes...
Autores principales: | Watanabe, Shin-ya, Numata, Shusuke, Iga, Jun-ichi, Kinoshita, Makoto, Umehara, Hidehiro, Ishii, Kazuo, Ohmori, Tetsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328599/ https://www.ncbi.nlm.nih.gov/pubmed/28260899 http://dx.doi.org/10.2147/NDT.S120038 |
Ejemplares similares
-
Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita, Masatoshi, et al.
Publicado: (2018) -
Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2017) -
No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population
por: Umehara, Hidehiro, et al.
Publicado: (2016) -
PT614. Altered Serotonin transporter mRNA expression in the peripheral leukocytes of obsessive-compulsive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016) -
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)